Inactive Instrument

Other languages IVERIC bio, Inc.

Equities

ISEE

US46583P1021

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

IVERIC bio, Inc. Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY? (avacincaptad pegol intravitreal solution) for Geographic Atrophy	23-09-18
European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy	23-08-17
Iveric Bio Receives U.S. FDA Approval for IZERVAY? (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy	23-08-04
Astellas US Holding, Inc. completed the acquisition of IVERIC bio, Inc. from BlackRock, Inc., Deep Track Capital, LP, The Vanguard Group, Inc. and others.	23-07-10
Insider Sell: Iveric Bio	23-06-06
Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears	23-05-17
IVERIC bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Insider Sell: Iveric Bio	23-05-03
Insider Sell: Iveric Bio	23-05-03
First Republic mord la poussière à son tour	23-05-02
En Direct des Marchés : TotalEnergies, Airbus, McPhy, Logitech, Astellas, Chegg, HSBC, Adidas...	23-05-02
MÄRKTE USA/Leichtes Minus vor Fed - JPM steigen nach Zuschlag für First Republic	23-05-01
Wall Street vlak gesloten	23-05-01
Sector Update: Health Care Stocks Rising in Late Afternoon Trading	23-05-01
Sector Update: Health Care Stocks Rising Monday Afternoon	23-05-01
Wall Street koerst af op hoger slot	23-05-01
Top Midday Gainers	23-05-01
ÜBERBLICK Unternehmen/29. April bis 1. Mai 2023	23-05-01
MÄRKTE USA/Uneinheitlich vor Fed - JPM nach Zuschlag für First Republic fest	23-05-01
IVERIC Bio Shares Jump on $5.9 Billion Deal to be Acquired by Astellas Pharma	23-05-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages IVERIC bio, Inc.

Equities

ISEE

US46583P1021

Other languages

Filters